Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 288
Selected: 0
NCT IDTitle
NCT02500940Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma
NCT03366415Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC
NCT07101159Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
NCT04421469Triprilimab(JS001) and Chemotherapy Combined With Local Treatment for Multiple Metastatic NPC
NCT03641820Cognitive Dysfunction in Patients With Cancer Pain
NCT05305859Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
NCT06078670PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors
NCT06775756Reducing Dose and Irradiated Volume in Cervical Prophylactic Irradiation for Nasopharyngeal Cancer
NCT05049811Effects of Mobile Medicine on Cancer Patients
NCT04436965Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
NCT06126393MRI Radiomics Combined With Pathomics on the Prediction of Molecular Classification and Prognosis of Endometrial Cancer
NCT05640726The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
NCT02597868A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)
NCT03566576Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel
NCT06572293Effect of Nurse-Led Individualized Follow-Up Intervention on Patients With Nasopharyngeal Carcinoma
NCT06242392The Correlation Between HRD Detection and the Efficacy of PARP Inhibitors in Ovarian Cancer
NCT05497076the Efficacy and Safety of Dalpiciclib Combined With Third-generation EGFR-TKI in Patients With EGFR Mutation and Meningial Metastasis in Non-small Cell Lung Cancer Progressing Through Third-generation TKI and Platinum-containing Two-drug Chemotherapy
NCT04074538the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT06039982A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer
NCT03001596Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC
NCT06218888A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases
NCT05035446Short-term Outcomes of SILS+1 Versus CLS for Distal Gastric Cancer
NCT04870905Tisleilizumab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
NCT03476057Next-generation Sequencing in Gastrointestinal Cancer
NCT04922567Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT06600841Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer
NCT03666221Nimotuzumab for Recurrent Nasopharyngeal Carcinoma
NCT04843215A Phase III Study Comparing Total and Partial Omentectomy for Patients With Advanced Gastric Cancer
NCT02448966Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
NCT07243418Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study
NCT04121039Study of the Apatinib Combine With POF Versus POF in Gastric Cancer
NCT06396585The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction
NCT05197933Safety of Laparoscopic Resection for Gastrointestinal Stromal Tumor on Unfavorable Anatomic Site of Stomach
NCT07185308Postbiotics Ameliorate Cachexia in Patients With Non-small-cell Lung Cancer
NCT03375515PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain
NCT05019690Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast Cancer
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT07013461International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
NCT06059261Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.
NCT05648994TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid Tumors
NCT01407822Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer
NCT06478472Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy
NCT02845986Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric Cancer
NCT03708536Bevacizumab Plus Capecitabin vs S-1 as Maintenance Treatment Following First-line Chemotherapy in the Patients With Advanced Colorectal Adenocarcinoma
NCT06827899Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
NCT03380689Phase I Study of Biweekly SIRB Regimen for Metastatic Colorectal Cancer
NCT04745741Evaluating the Rationality of the International Guideline About Selective Coverage of Level Ib in CTV With NPC
NCT05597527Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
NCT03137004Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric Cancer
NCT02886195EGFR-TKIs Combine Chemotherapy as First-line Therapy for Patients With Advanced EGFR Mutation-positive NSCLC